|
embryonic day 15.5
|
EFO_0002566 |
|
|
embryonic day 14.5
|
EFO_0002565 |
|
|
salivary gland adenoid cystic carcinoma
|
DOID_4866 |
|
|
embryonic day 17.5
|
EFO_0002568 |
|
|
Unverricht-Lundborg syndrome
|
DOID_3535 |
|
|
progressive myoclonus epilepsy
|
DOID_891 |
|
|
embryonic day 16.5
|
EFO_0002567 |
|
|
embryonic day 18
|
EFO_0002569 |
|
|
Gorham's disease
|
DOID_4837 |
|
|
anxiogenic
|
CHEBI_137736 |
|
|
dermatofibrosarcoma protuberans
|
DOID_3507 |
|
|
tick-borne encephalitis
|
DOID_0050175 |
|
|
myoepithelial carcinoma
|
DOID_4838 |
|
|
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
|
CHEBI_64964 |
|
|
chemokine receptor 2 antagonist
|
CHEBI_149711 |
|
|
adenosquamous carcinoma
|
DOID_4830 |
|
|
hyperglycemic agent
|
CHEBI_76916 |
|
|
cerebellar astrocytoma
|
DOID_4848 |
|
|
cerebellum cancer
|
DOID_4205 |
|
|
autoimmune polyendocrine syndrome type 2
|
DOID_0050168 |
|
